Share on StockTwits

Abaxis (NASDAQ:ABAX) Director Richard Bastiani sold 4,000 shares of the company’s stock on the open market in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $41.88, for a total transaction of $167,520.00. Following the completion of the sale, the director now directly owns 49,400 shares of the company’s stock, valued at approximately $2,068,872. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

A number of analysts have recently weighed in on ABAX shares. Analysts at TheStreet upgraded shares of Abaxis from a “hold” rating to a “buy” rating in a research note on Friday, May 16th. Separately, analysts at Canaccord Genuity raised their price target on shares of Abaxis from $34.00 to $39.00 in a research note on Wednesday, May 14th. Finally, analysts at Feltl & Co. upgraded shares of Abaxis from a “sell” rating to a “hold” rating in a research note on Friday, April 25th. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $36.75.

Shares of Abaxis (NASDAQ:ABAX) traded down 0.90% during mid-day trading on Wednesday, hitting $41.62. 122,914 shares of the company’s stock traded hands. Abaxis has a one year low of $32.11 and a one year high of $51.84. The stock has a 50-day moving average of $41.16 and a 200-day moving average of $39.38. The company has a market cap of $934.7 million and a P/E ratio of 66.67.

Abaxis (NASDAQ:ABAX) last announced its earnings results on Thursday, April 24th. The company reported $0.17 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.19 by $0.02. The company had revenue of $42.04 million for the quarter, compared to the consensus estimate of $45.74 million. During the same quarter last year, the company posted $0.30 earnings per share. Abaxis’s revenue was down 15.8% compared to the same quarter last year. On average, analysts predict that Abaxis will post $0.91 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Tuesday, June 17th. Investors of record on Tuesday, June 3rd will be given a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 0.96%. The ex-dividend date of this dividend is Friday, May 30th.

Abaxis, Inc (NASDAQ:ABAX) develops, manufactures, markets and sells blood analysis systems for use in the human or veterinary patient-care setting to provide clinicians with rapid blood constituent measurements.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.